INTELLECTUAL PROPERTY

OncoLab Diagnostics has secured the following intellectual property rights:

Non-Invasive Cancer Diagnosis

Non-invasive method for the diagnosis of adenocarcinoma or their precursor lesions in females by analyzing cells and preparing epithelial cells of a sample obtained from a rinse of the uterine cavity and optionally the fallopian tubes, and - performing analysis in said cells to determine an abnormality associated with ovarian or endometrial cancer, the abnormality being indicative of adenocarcinoma or their precursor lesions.

Publication No.:
CA20132863144 20130131, EP20120153340 20120131, WO2013EP51899 20130131

Composition and method for determination of CK19 expression

Method for quantitative determination of CK19 mRNA-positive cells in a biological sample.

Publication No.:
WO2007020081, EP1915461, US20140057265, CN101365800

Novel Tumor marker determination

Diagnostic tests for circulating tumor cells in ovarian cancer.

Publication No.:
WO2012123536, CA2830005, EP2686439, US20120238458

Novel Tumor marker determination

Diagnostic tests for circulating tumor cells in breast, ovarian, endometrial and cervical cancer.

Publication No.:
EP2309273, US20140018259

Method and kit for diagnosis of a cancerous disease, method for determining the reaction of a patient to the treatment for a cancerous disease medicament for the prophylaxis or treatment of a cancerous disease

Diagnostic tests for circulating tumor cells in ovarian cancer.

Publication No.:
WO2006018290, EP1786929

Multimarker panel

Diagnostic test for early detection of ovarian cancer based on RNA biomarkers and RNA/protein biomarker models.

Publication No.:
WO2012069659, CA2818976, EP2643477, US20130303400

oncolab_logo_transparent_1246x281

© OncoLab Diagnostics GmbH 2019

OncoLab Diagnostics GmbH
Viktor-Kaplan-Strasse 2
2700 Wiener Neustadt / Lower Austria
Austria